30
Views
6
CrossRef citations to date
0
Altmetric
Issues in Clinical Trials

Missing data

&
Pages 48-51 | Published online: 10 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

MarcK. Walton. (2009) Addressing and Advancing the Problem of Missing Data. Journal of Biopharmaceutical Statistics 19:6, pages 945-956.
Read now
Richard Buchsbaum, Petra Kaufmann, Alexandra I. Barsdorf, Rachel Arbing, Jacqueline Montes, John L.P. Thompson & For The QALS Study Group. (2009) Web-based data management for a phase II clinical trial in ALS. Amyotrophic Lateral Sclerosis 10:5-6, pages 374-377.
Read now
Petra Kaufmann, Gilbero Levy, Jacquelina Montes, Richaro Buchsbaum, Alexandra I. Barsdorf, Vanessa Battista, Rachel Arbing, Paul H. Gordon, Hiroshi Mitsumoto, Brvce Levin, John L. P. Thompson, Petra Kaufmann, Gilbero Levy, Jacquelina Montes, Richaro Buchsbaum, Alexandra I. Barsdorf, Vanessa Battista, Rachel Arbing, Paul H. Gordon, Hiroshi Mitsumoto, Brvce Levin & John L. P. Thompson. (2007) Excellent inter‐rater, intra‐rater, and telephone‐administered reliability of the ALSFRS‐R in a multicenter clinical trial. Amyotrophic Lateral Sclerosis 8:1, pages 42-46.
Read now

Articles from other publishers (3)

Hiroshi Mitsumoto, Codruta Chiuzan, Madison Gilmore, Yuan Zhang, Zachary Simmons, Sabrina Paganoni, Yasushi Y. Kisanuki, Lorne Zinman, Omar Jawdat, Eric Sorenson, Mary Kay Floeter, Erik P. Pioro, J. Americo M. Fernandes Filho, Daragh Heitzman, Christina Nicole Fournier, Bjorn Oskarsson, Terry Heiman‐Patterson, Nicholas Maragakis, Nanette Joyce, Ghazala Hayat, Sharon Nations, Stephen Scelsa, David Walk, Lauren Elman, Jonathan Hupf & Brittany McHale. (2019) Primary lateral sclerosis (PLS) functional rating scale: PLS‐specific clinimetric scale. Muscle & Nerve 61:2, pages 163-172.
Crossref
Paolo Messina & Ettore Beghi. (2012) Modeling drop-outs in amyotrophic lateral sclerosis. Contemporary Clinical Trials 33:1, pages 218-222.
Crossref
Petra Kaufmann, John L.P. Thompson, Gilberto Levy, Richard Buchsbaum, Jeremy Shefner, Lisa S. Krivickas, Jonathan Katz, Yvonne Rollins, Richard J. Barohn, Carlayne E. Jackson, Ezgi Tiryaki, Catherine Lomen‐Hoerth, Carmel Armon, Rup Tandan, Stacy A. Rudnicki, Kourosh Rezania, Robert Sufit, Alan Pestronk, Steven P. Novella, Terry Heiman‐Patterson, Edward J. Kasarskis, Erik P. Pioro, Jacqueline Montes, Rachel Arbing, Darleen Vecchio, Alexandra Barsdorf, Hiroshi Mitsumoto & Bruce Levin. (2009) Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Annals of Neurology 66:2, pages 235-244.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.